pharmaphorum

MARCH 18, 2021

An EMA advisory committee’s review of AstraZeneca’s COVID-19 has concluded that there is no increase in the overall risk of blood clots with this vaccine. And because the vaccine is effective in preventing COVID-19 disease – which in itself is a cause of blood clots – it “likely reduces the risk of thrombotic events overall.”.

Vaccines 105

Vaccines Immunization 105

European Pharmaceutical Review

AUGUST 30, 2022

It has highlighted the value of cutting-edge technologies, such as messenger RNA (mRNA) vaccines, and reinforced the industry’s understanding of the power of collaboration, including with contract partners such as contract development and manufacturing organisations (CDMOs). The rise of the nasal vaccine route.

Vaccines 119

Vaccines Immunization 119

Fierce Pharma

JUNE 29, 2023

While Dupixent often steals the show, Sanofi isn’t sleeping on its vaccine franchise. | By 2030, Sanofi figures its immunizations could generate more than €10 billion in annual sales, the company said during a vaccines R&D event Thursday.

Vaccines 77

Vaccines Immunization 77

pharmaphorum

NOVEMBER 17, 2020

Pfizer has begun a pilot delivery programme in the US for its experimental COVID-19 vaccine, as the company seeks to overcome logistical challenges caused by its ultra-cold storage requirements. The vaccine developed in partnership with Germany’s BioNTech has been shown to be 90% effective in clinical trials.

Vaccines 78

Vaccines Immunization FDA 78

Hospital Pharmacy Europe

OCTOBER 2, 2024

Pharmacist Dr João Gonçalves PhD considers the real-world evidence of a recent study demonstrating the feasibility and efficacy of a personalised peptide vaccine for glioblastoma – one of the most malignant primary brain tumours in adults. The median overall survival (OS) for the entire cohort was 31.9

Vaccines 52

Vaccines Immunization Chemotherapy Hospitals 52

pharmaphorum

DECEMBER 7, 2020

China’s Sinovac has raised $515 million to increase its distribution and production capacity as clinical development of its potential coronavirus vaccine nears conclusion. Sinovac has a coronavirus vaccine in late-stage development, which is undergoing large-scale trials in Brazil, Pakistan, Indonesia and Chile.

Vaccines 59

Vaccines Immunization 59

Pharmaceutical Technology

NOVEMBER 20, 2022

Health Canada has granted expanded authorisation for Novavax ’s Covid-19 vaccine (Recombinant protein, Adjuvanted) [Nuvaxovid; NVX-CoV2373] as a homologous booster for usage in adults aged 18 and above. The vaccine is indicated for active immunisation to prevent the disease.

Vaccines 59

Vaccines Adverse Reactions Immunization 59

Pharmaceutical Technology

JUNE 8, 2023

Gritstone bio has reported interim results from an ongoing Phase 1 study evaluating the company’s self-amplifying mRNA (samRNA) vaccine as a boost against Covid-19 (CORAL-BOOST). The Phase I CORAL-BOOST dose-escalation trial (NCT05148962) evaluated Gritstone’s samRNA candidate (GRT-R910) in previously vaccinated healthy older adults.

Vaccines 52

Vaccines Immunization Communication 52

European Pharmaceutical Review

AUGUST 3, 2022

The COVID-19 pandemic has demonstrated the need for an improved vaccine approach to temper the serious threat of constantly mutating viruses, such as influenza and coronaviruses, on global health. These spontaneous mutation events are quite common and often do not lead to an improved version of the pathogen.

Vaccines 95

Vaccines Immunization 95

European Pharmaceutical Review

DECEMBER 14, 2022

and Merck have announced that a Phase IIb trial ( NCT03897881 ) of a personalised mRNA cancer vaccine (mRNA-4157/V940), in combination with KEYTRUDA ® , Merck’s anti-PD-1 therapy, demonstrated the first randomised evidence that a personalised neoantigen approach may be beneficial in treating melanoma. Moderna, Inc.

Vaccines 116

Vaccines Immunization 116

pharmaphorum

AUGUST 27, 2020

Moderna has said that its coronavirus vaccine stimulated an immune response in older people in phase 1 trials, suggesting that the jab is effective in the age groups most susceptible to COVID-19. There were also no serious adverse events reported. The US has also bought 100 million doses of the mRNA vaccine for more than $1.5

Vaccines 111

Vaccines Immunization 111

pharmaphorum

MARCH 31, 2021

Germany and Canada have both slapped restrictions on the AstraZeneca vaccine, recommending its use only in older patients, because of concerns over a link with blood clots. According to STIKO the side effect occurred four to 16 days after vaccination and was predominantly seen in people under 60 years of age.

Vaccines 116

Vaccines Immunization 116

European Pharmaceutical Review

OCTOBER 21, 2022

GSK announced Shingrix (Zoster Vaccine Recombinant, Adjuvanted), the first approved shingles vaccine to combine a non-live antigen with a GSK-made adjuvant, can prevent shingles (herpes zoster) for at least decade. An interim analysis conducted over more than four years of long-term follow-up (LTFU) showed vaccine efficacy was 81.6

Vaccines 105

Vaccines Immunization 105

pharmaphorum

APRIL 30, 2021

The NHS app could be used a kind of vaccine passport, according to UK government sources, although it is unclear how far the project has progressed. . NHS England’s app is connected to GP services in England and linked to personal health data and as such could be used to show a person’s vaccine status before travelling.

Vaccines 93

Vaccines Immunization 93

European Pharmaceutical Review

DECEMBER 15, 2023

Moderna and MSD have announced follow-up data from the Phase IIb clinical trial evaluating cancer vaccine mRNA-4157 (V940) in combination with MSD’s Keytruda in patients with resected high-risk melanoma. Adverse events observed with mRNA-4157 in KEYNOTE-942 remain consistent with those previously reported.

Vaccines 115

Vaccines Research Laboratories Immunization 115

pharmaphorum

APRIL 6, 2021

People in the UK will start receiving doses of Moderna’s COVID-19 vaccine in around two weeks’ time, according to vaccines minister Nadhim Zahawi. Moderna’s vaccine is around 94% effective at preventing the disease, in line with the results seen from the Pfizer/BioNTech shot, which is also based around mRNA technology.

Vaccines 80

Vaccines Immunization 80

Hospital Pharmacy Europe

DECEMBER 14, 2022

mRNA-4157/V940 which represents a personalised cancer vaccine has been found effective when combined with pembrolizumab in advanced melanoma. mRNA-4157/V940 is designed to stimulate an immune response by generating a specific T cell action based on the unique mutational signature of a patient’s tumour.

Vaccines 98

Vaccines Immunization Hospitals 98

pharmaphorum

JANUARY 8, 2021

As COVID-19 vaccines are hastily deployed in the UK for priority groups, a debate rages over the government’s controversial strategy to delay time between vaccine doses. When the UK announced the approval of the Pfizer-BioNTech and Oxford-AstraZeneca COVID-19 vaccines, it marked an exciting moment for the nation.

Vaccines 59

Vaccines Immunization Medical Schools FDA 59

pharmaphorum

JANUARY 8, 2021

As COVID-19 vaccines are hastily deployed in the UK for priority groups, a debate rages over the government’s controversial strategy to delay time between vaccine doses. When the UK announced the approval of the Pfizer-BioNTech and Oxford/AstraZeneca COVID-19 vaccines, it marked an exciting moment for the nation.

Vaccines 59

Vaccines Immunization Medical Schools FDA 59

PQA

APRIL 25, 2025

Introducing clinical servicessuch as compounding, immunizations, and mobile vaccine outreachare also giving a financial lifeline to some pharmacies. Expanding into niche services is a strategy many pharmacies are finding success with.

Independent Pharmacies 52

Independent Pharmacies Compounding Immunization Vaccines 52

The Checkup by Singlecare

JULY 8, 2024

Rinvoq works by lowering your immune system activity,” said Joanne Nguyen, Pharm.D. , By suppressing a specific pathway in the immune system, Rinvoq reduces inflammation and relieves symptoms associated with inflammatory conditions. a clinical pharmacy practitioner in Georgia. an ambulatory care pharmacist in northern Indiana.

Insurance 97

Insurance Dosage Immunization Labelling 97

The Checkup by Singlecare

APRIL 6, 2023

Vaccines have been an essential part of protecting public health for decades. However, despite the overwhelming evidence for their effectiveness and safety, there has been an increasing trend of vaccine hesitancy in recent years. What is vaccine hesitancy? Are there any long-term risks with vaccines?

Vaccines 52

Vaccines Immunization Communication Pharmaceutical Companies 52

Hospital Pharmacy Europe

NOVEMBER 7, 2022

The mRNA-1273 vaccine has been shown to generate an antibody response in children from 6 months which is non-inferior to that of young adults. However, whether the vaccine remains safe and able to elicit a satisfactory antibody response in children from 6 months of age is uncertain and was the purpose of the present study.

Vaccines 52

Vaccines Immunization Hospitals 52

pharmaphorum

FEBRUARY 10, 2021

Given the large unmet clinical need in this oncology indication and aligned with recent clinical trial progress, the Triple Negative Breast Cancer (TNBC) Drug Development Digital Summi t has been created to provide insight into industry- and academic-led clinical programs developing immune checkpoint, DDR inhibitor, ADC and other novel agents.

Immunization 133

Immunization Vaccines 133

pharmaphorum

JANUARY 13, 2023

These therapies have incredible potential to fight cancer and other diseases using the patient’s own immune system. And that’s without even getting into digital medicines and digital therapeutics, mRNA vaccines and lessons from COVID, investment trends, or talent and workforce challenges.

FDA 98

FDA Immunization Vaccines 98

BuzzRx

SEPTEMBER 6, 2022

Rheumatoid arthritis (RA) is an inflammatory autoimmune disease in which the body’s immune system mistakenly attacks the lining of the joints (the synovium), causing pain and inflammation, which leads to joint damage over time. These drugs work by suppressing an overactive immune system and inflammatory response.

Immunization 52

Immunization Vaccines 52

Pharmaceutical Technology

JULY 29, 2022

Furthermore, a 91% and 100% cystectomy avoidance rate and bladder cancer overall survival, respectively, were observed at 24 months without any serious adverse events (SAE). In January, ImmunityBio and Amyris have concluded a joint venture (JV) agreement announced previously to accelerate the marketing of a Covid-19 vaccine.

FDA 105

FDA Labelling Immunization Vaccines 105

Digital Pharmacist

OCTOBER 25, 2023

You could also encourage your staff to wear blue shirts, pins, or ribbons, and use the resources available to make it a memorable event that keeps diabetes care and prevention top-of-mind. Promote Routine Immunizations People with diabetes are at a higher risk of complications from infections.

Immunization 105

Immunization Vaccines 105

The Checkup by Singlecare

OCTOBER 1, 2024

Schedule a special health event for patients Organizing a health event can be a way to show appreciation for your patients. These community events can help promote your pharmacy’s services and build and strengthen relationships with your patients. According to the APhA, 90% of the U.S.

Patient Care 52

Patient Care Immunization Vaccines 52

Pharmacy Times

SEPTEMBER 12, 2024

Programs can take several forms, including on-site clinics, voucher programs, and in-store events

Immunization 56

Immunization Vaccines 56

pharmaphorum

SEPTEMBER 22, 2022

CAR-Ts can sometimes cause cytokine release syndrome (CRS), when the immune system goes into overdrive and causes dangerous inflammation, which means patients have to receive prophylactic immune-suppressing drugs that can limit the efficacy of treatment.

Immunization 52

Immunization Vaccines 52

Digital Pharmacist

JANUARY 16, 2023

From cancer prevention to diabetes awareness, these events help bring communities together. World Immunization Week: April 24-30. National Immunization Awareness Month. National Influenza Vaccination Week: December 6-12. Also, don’t forget to promote these awareness events on your website and at your pharmacy.

Immunization 98

Immunization Vaccines Communication Hospitals 98

The Checkup by Singlecare

NOVEMBER 30, 2023

In the event of an acetaminophen interaction with concerns of acute toxicity, be it an accidental or intentional overdose, contact the national poison control hotline at 800-222-1222 to be connected to a poison control center in your area. However, after vaccine administration, ACIP recommends use for fever treatment and local pain.

Immunization 98

Immunization Vaccines FDA Labelling 98

The Checkup by Singlecare

JANUARY 22, 2023

In the fall and winter, when the weather is cold, people are closer to one another indoors—at school, work, gatherings, and other indoor events. Because the flu can have serious complications, getting a yearly flu vaccine is important. Babies and young children also need a pneumonia vaccine. What is the best way to treat a cold?

Vaccines 98

Vaccines Immunization 98

DiversifyRx

DECEMBER 11, 2024

Gain 50 new flu vaccine patients in January. Identify Key Areas of Focus: Think about the services or products you want to promote, such as weight loss programs, immunizations, or non-PBM revenue streams. May: Immunization Awareness Boost summer travel vaccine promotions. Week 4: Promote a special offer or event.

Vaccines 52

Vaccines Immunization Independent Pharmacies 52

European Pharmaceutical Review

SEPTEMBER 4, 2023

Maciej Adamczyk and Monika Pyzio-Michalik, DBS Law Firm EVENT PREVIEW Modern methods in microbiology and analytics PharmaLab Congress DRUG DELIVERY Dry powder delivery to the lungs Jnanadeva Bhat, ACG EVENT PREVIEW CPHI Barcelona 2023: what to expect Featuring company profiles from BioSpectra, Lonza and Ajinomoto VACCINE DEVELOPMENT The imperative (..)

Packaging 97

Packaging Vaccines Immunization 97

Roots Analysis

FEBRUARY 23, 2024

Humanization: In many cases, discovered antibodies are highly immunogenic and may cause unwanted / exaggerated immune response in the hosts. Advanced treatments, particularly those that focus on the body’s immune system, will require a diverse array of antibodies for research and medicine production.

Immunization 40

Immunization FDA Vaccines 40